1009367-63-8 Usage
Description
1-Azetidinecarboxylic acid, 3-(2H-tetrazol-5-yl)-, 1,1-diMethylethyl ester is a chemical compound that is used in organic synthesis as a reagent and as a building block for pharmaceuticals and agrochemicals. It is an ester derivative of azetidinecarboxylic acid, which is a bioactive compound with potential medicinal properties. The 3-(2H-tetrazol-5-yl) substituent in the molecule is a tetrazole ring, which is a common motif in pharmacologically active compounds. The 1,1-diMethylethyl ester group adds stability to the compound and allows for easy handling and storage. Overall, this chemical has potential applications in drug discovery and development.
Uses
Used in Pharmaceutical Industry:
1-Azetidinecarboxylic acid, 3-(2H-tetrazol-5-yl)-, 1,1-diMethylethyl ester is used as a building block for the development of new pharmaceuticals due to its bioactive properties and the presence of a tetrazole ring, which is a common motif in pharmacologically active compounds.
Used in Agrochemical Industry:
1-Azetidinecarboxylic acid, 3-(2H-tetrazol-5-yl)-, 1,1-diMethylethyl ester is used as a reagent in the synthesis of agrochemicals, contributing to the development of new compounds for agricultural applications.
Used in Organic Synthesis:
1-Azetidinecarboxylic acid, 3-(2H-tetrazol-5-yl)-, 1,1-diMethylethyl ester is used as a reagent in organic synthesis, providing a stable and easily handled compound for the creation of various organic compounds.
Check Digit Verification of cas no
The CAS Registry Mumber 1009367-63-8 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,0,9,3,6 and 7 respectively; the second part has 2 digits, 6 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1009367-63:
(9*1)+(8*0)+(7*0)+(6*9)+(5*3)+(4*6)+(3*7)+(2*6)+(1*3)=138
138 % 10 = 8
So 1009367-63-8 is a valid CAS Registry Number.
1009367-63-8Relevant articles and documents
NEW THIADIAZOLE DERIVATIVES
-
Page/Page column 49, (2011/04/24)
The present invention relates to thiadiazole derivatives of formula (I), to processes for their preparation and to pharmaceutical compositions containing them. These compounds are potent agonists of S1P1 receptors and thus, they are useful In the treatment, prevention or suppression of diseases and disorders known to be susceptible to improvement by sphingosine-1-phosphate receptors agonists (S1P1), such as autoimmune diseases, chronic immune and inflammatory diseases, transplant rejection, malignant neoplastic diseases, angiogenic-related disorders, pain, neurological diseases, viral and infectious diseases.
CYCLIC 11-BETA HYDROXYSTEROID DEHYDROGENASE TYPE I INHIBITORS
-
Page/Page column 104-105, (2008/06/13)
Novel compounds are provided which are 11-beta-hydroxysteroid dehydrogenase type I inhibitors. 11-Beta-hydroxysteroid dehydrogenase type I inhibitors are useful in treating, preventing, or slowing the progression of diseases requiring 11-beta-hydroxysteroid dehydrogenase type I inhibitor therapy. These novel compounds have the structure (I) enantiomers, diastereomers, solvates, or salts thereof, wherein A, W, X and Z are defined herein.
